Shock therapy: high norepinephrine doses linked to death risk
NCT ID NCT05032261
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 100 ICU patients with circulatory shock who received norepinephrine, a drug that raises blood pressure. Researchers wanted to see if a certain dose was linked to higher death rates within 5 days. They also studied how long patients needed the drug and the total amount given. The goal was to find a dose limit where more medicine no longer helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRCULATORY COLLAPSE AND SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France